Aethlon lists on NASDAQ

Aethlon Medical (OTC:AEMD) said yesterday that the NASDAQ Stock Market has approved its application to begin trading on the Nasdaq Capital Market, beginning July 13. The company’s shares will be traded on the Nasdaq Capital Market under its existing trading symbol AEMD, the San Diego, Calif.-based company said. “Trading on Nasdaq is a pivotal corporate milestone that will help raise the visibility of our therapeutic endeavors and increase the appeal of our shares to mutual funds, pension funds, and other institutional investors that may have previously been restricted from trading our shares,” CEO Jim Joyce said in a press release. Last month, Aethlon announced the opening of a $6 million follow-on offering at $6.30 per share, with funds slated for the clinical advancement of the company’s Hemopurifier and for general purposes. The post Aethlon lists on NASDAQ appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blood Management Business/Financial News Wall Street Beat Aethlon Medical Inc. Source Type: news